common side effects of glp-1 receptor agonists – The Science Behind the Success – Transformation Weight Control Clinical Recommendations to Manage Gastrointestinal

Gastric inhibitory polypeptide (GIP) and glucagonlike peptide1 (GLP1) are the two primary incretin hormones secreted from the intestine on ingestion of glucose or nutrients to stimulate insulin secretion from pancreatic cells

This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes

John Roxborough, MD, we serve patients in Bethesda, Wheaton, Potomac, Falls Church, Tysons Corner, Gaithersburg, Baltimore and McLean Virgin

The American Society of Anesthesiologists (ASA) recommends withholding these drugs before surgery, but definitive guidelines remain unclear

Society guidelines have left clinicians with some questionable recommendations